Maravai LifeSciences Holdings Dirección
Dirección controles de criterios 3/4
El CEO de Maravai LifeSciences Holdings' es Trey Martin , nombrado en Jul 2023, tiene una permanencia de menos de un año. compensación anual total es $14.52M, compuesta por 4.5% salario y 95.5% primas, incluidas acciones y opciones de la empresa. posee directamente un 0.053% de las acciones de la empresa, por valor de $1.02M. La antigüedad media del equipo directivo y de la junta directiva es de 1.5 años y 3.4 años, respectivamente.
Información clave
Trey Martin
Chief Executive Officer (CEO)
US$2.3m
Compensación total
| Porcentaje del salario del CEO | 32.6% |
| Permanencia del CEO | less than a year |
| Participación del CEO | 0.05% |
| Permanencia media de la dirección | 1.9yrs |
| Promedio de permanencia en la Junta Directiva | 3.5yrs |
Actualizaciones recientes de la dirección
Recent updates
An Intrinsic Calculation For Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Suggests It's 23% Undervalued
Apr 07
Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Stocks Shoot Up 28% But Its P/S Still Looks Reasonable
Feb 28Revenues Working Against Maravai LifeSciences Holdings, Inc.'s (NASDAQ:MRVI) Share Price
Dec 19Need To Know: Analysts Just Made A Substantial Cut To Their Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Estimates
Aug 14Are Investors Undervaluing Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) By 27%?
Feb 28Is Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Expensive For A Reason? A Look At Its Intrinsic Value
Nov 01Maravai Lifesciences temporarily reinstates Carl Hull as CEO
Oct 19Maravai LifeSciences appoints former Danaher executive as CEO
Oct 03Maravai LifeSciences Holdings GAAP EPS of $0.53 beats by $0.15, revenue of $242.73M beats by $9.51M
Aug 04Estimating The Intrinsic Value Of Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI)
Jun 27Maravai LifeSciences Holdings, Inc.'s (NASDAQ:MRVI) Intrinsic Value Is Potentially 25% Below Its Share Price
Mar 29Maravai Faces Skeptical Investors As Pandemic Enters New Period
Jan 27Maravai LifeSciences Holdings, Inc.'s (NASDAQ:MRVI) Share Price Could Signal Some Risk
Dec 02Maravai LifeSciences Holdings, Inc.'s (NASDAQ:MRVI) Intrinsic Value Is Potentially 26% Below Its Share Price
Oct 07Is Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Worth US$41.7 Based On Its Intrinsic Value?
Jul 01Maravai LifeSciences: The Future Beyond Covid Vaccines
Jun 29Need To Know: Analysts Are Much More Bullish On Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI)
May 13Análisis de compensación del CEO
| Fecha | Compensación total | Salario | Ingresos de la empresa |
|---|---|---|---|
| Dec 31 2023 | US$2m | US$750k | -US$119m |
| Sep 30 2023 | n/a | n/a | US$25m |
| Jun 30 2023 | n/a | n/a | US$75m |
| Mar 31 2023 | n/a | n/a | US$153m |
| Dec 31 2022 | US$15m | US$660k | US$220m |
Compensación vs. Mercado: La compensación total de Trey($USD2.30M) está por debajo de la media de empresas de tamaño similar en el mercado US ($USD5.66M).
Compensación vs. Ingresos: La compensación de Trey ha sido consistente con los resultados de la empresa en el último año.
CEO
Trey Martin (48 yo)
less than a year
Permanencia
US$2,301,864
Compensación
Mr. William E. Martin, III, also known as Trey, was President of Biologics Safety Testing of Maravai LifeSciences Holdings, Inc. since December 5, 2022 until July 27, 2023 and is its Chief Executive Office...
Equipo directivo
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| Co-Founder & Executive Chairman | 3.5yrs | US$5.22m | 0.076% $ 1.7m | |
| Chief Executive Officer | less than a year | US$2.30m | 0.053% $ 1.2m | |
| Executive VP & CFO | 7yrs | US$2.79m | 0.021% $ 473.3k | |
| Executive VP & Chief Administrative Officer | 1.9yrs | US$2.83m | 0.027% $ 602.7k | |
| Executive VP & GM of Cygnus Technologies | 6.6yrs | US$2.26m | 0.019% $ 434.9k | |
| President of Nucleic Acid Production | 1.2yrs | US$2.99m | 0.023% $ 514.9k | |
| Senior Director of Investor Relations | no data | sin datos | sin datos | |
| Executive VP | 3.5yrs | US$701.40k | 0.019% $ 429.7k | |
| Executive VP & Chief Commercial Officer | 1.3yrs | sin datos | 0.015% $ 334.9k | |
| Chief Innovation Officer | 1.3yrs | sin datos | sin datos |
1.9yrs
Permanencia media
54yo
Promedio de edad
Equipo directivo experimentado: El equipo directivo de MRVI no se considera experimentado ( 1.5 años antigüedad media), lo que sugiere un nuevo equipo.
Miembros de la Junta
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| Co-Founder & Executive Chairman | 3.5yrs | US$5.22m | 0.076% $ 1.7m | |
| Independent Director | less than a year | US$435.03k | sin datos | |
| Non-Independent Director | 3.5yrs | US$370.48k | 0.0032% $ 72.7k | |
| Non-Independent Director | 3.5yrs | US$367.98k | 0.0032% $ 72.7k | |
| Independent Director | 3.5yrs | US$360.48k | 0.020% $ 462.5k | |
| Independent Director | 3.5yrs | US$395.48k | 0.024% $ 547.6k | |
| Non-Independent Director | 3.5yrs | US$360.48k | 0.0032% $ 72.7k | |
| Non-Independent Director | 3.5yrs | US$360.48k | 0.0032% $ 72.7k | |
| Independent Director | 3.5yrs | US$367.98k | 0.013% $ 287.2k | |
| Independent Director | 3.5yrs | US$387.98k | 0.047% $ 1.1m | |
| Independent Director | 3.5yrs | US$392.98k | 0.0092% $ 207.3k |
3.5yrs
Permanencia media
58yo
Promedio de edad
Junta con experiencia: La junta directiva de MRVI se considera experimentada (3.4 años de antigüedad promedio).